Skip to main content
Premium Trial:

Request an Annual Quote

Becton Dickinson Nabs FDA EUA for COVID-19, Influenza, RSV Test

NEW YORK – Becton Dickinson announced on Wednesday that it has received Emergency Use Authorization from the US Food and Drug Administration for its combination COVID-19, influenza A/B, and respiratory syncytial virus test. 

The RT-PCR assay runs on the BD Max Molecular Diagnostic System and returns results in as little as two hours from a nasal or nasopharyngeal swab, BD said in a statement. The Respiratory Viral Panel can identify and distinguish whether someone has one of the viruses or some combination of all three. It is authorized for use in laboratories that meet requirements to perform moderate- or high-complexity tests, according to the authorization document from the FDA.

"While fears of a 'tripledemic' this respiratory season have largely diminished, accurately differentiating influenza and RSV from COVID-19 and providing appropriate treatment remains a challenge for our customers," Nikos Pavlidis, VP of molecular diagnostics at BD, said in a statement. The test "provides the ability to identify multiple pathogens using a single sample and can quickly pinpoint the causative virus or viruses and enable clinicians to administer appropriate treatment early in the course of infection."

The test was CE marked in May 2022 and funded in part by federal funds from the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority, the Franklin Lakes, New Jersey-based firm said. 

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.